Welcome!

News Feed Item

DIA Names Stephen P. Spielberg Editor-in-Chief of TIRS Journal

FDA Deputy Commissioner to Bring New Vision and Leadership to DIA

HORSHAM, Pa., Jan. 22, 2013 /PRNewswire/ -- DIA today announced the arrival of Stephen P. Spielberg, M.D., Ph.D., as editor-in-chief of the newly launched, official DIA peer-reviewed scientific journal, Therapeutic Innovation & Regulatory Science (TIRS). Spielberg comes to DIA on the heels of his tenure at the U.S. Food and Drug Administration (FDA), where he has served since September 2011 as deputy commissioner for medical products and tobacco. Under Spielberg's seasoned, distinguished guidance, TIRS is slated to become the premiere guide for professionals involved in the worldwide discovery, development, regulation, monitoring and marketing of medicine, medical devices and diagnostic products.

"We are immensely excited to have such a respected, celebrated and influential leader in the pharmaceutical industry to guide TIRS in becoming the foremost trusted resource for understanding and advancing the drug development industry and regulatory affairs," said DIA Worldwide Executive Director Paul Pomerantz. "Dr. Spielberg's commitment to fostering innovation and collaboration across all pillars of the industry will drive conversations that enable our members and partners to share knowledge and work together as never before."

FDA Commissioner Margaret Hamburg, who announced today that Spielberg will depart FDA on Feb. 15 and assume his DIA role in March, said Spielberg's leadership and wise counsel will be missed. He has been a key member of her senior management team and a terrific spokesman for FDA, supporting invaluable work performed for drugs, biologics, medical devices and tobacco products, Hamburg said.

"He has been an important partner in helping the agency toward a more integrated approach to medical product evaluation … working together with center leadership to address the rapid changes in human biology and therapeutic interventions, and in helping optimize FDA's approach to evolving areas such as personalized medicine," Hamburg said.

For an in-depth view of Dr. Spielberg's vision for TIRS, see his full interview at DIA headquarters at http://youtu.be/Qvnu3nC_Cn0.

With a career spanning more than 35 years in medicine, academia, the pharmaceutical industry and regulatory affairs, Spielberg brings remarkable experience and leadership to DIA's journal. At FDA, Spielberg was integral to advancing regulatory science through esteemed leadership and determined collaboration. Spielberg formerly served as executive director of exploratory biochemical toxicology and of clinical and regulatory development at Merck Research Laboratories, and was vice president for pediatric drug development at Johnson & Johnson. While at Johnson & Johnson, he chaired the Pediatric Task Force for PhRMA, represented the pharmaceutical industry on the FDA Pediatric Advisory Subcommittee and on pediatric legislative initiatives in the United States and European Union, and was the rapporteur for the Pediatric ICH Initiative to harmonize pediatric drug development regulations among Europe, Japan and the United States.  

More recently, he was the chair in pediatric pharmacogenomics and director of the Center for Personalized Medicine and Therapeutic Innovation at Children's Mercy Hospital, Kansas City, Mo., as well as the dean of Dartmouth Medical School and vice president for health affairs at Dartmouth College. Spielberg also served on the board of directors of the Foundation for the National Institutes of Health, the FDA science board advisory committee and the executive board of Observational Medical Outcomes Partnership.

"We have a challenge of determining how best to inform one another about science and how that converts into the discovery, development, regulation and use of new medical products," Spielberg said. "My vision for TIRS will bring together members of all sectors that have a stake in the future of human health to discuss key issues facing the industry and regulatory affairs—and to translate human brilliance and discovery into real products."

Spielberg also brings a wealth of editorial experience to DIA. He previously was associate editor of Drug Metabolism and Disposition and serves on the editorial boards of multiple pediatric and pharmacology journals. DIA is honored to welcome such a distinguished leader to help facilitate knowledge exchange and collaboration to advance the drug development industry worldwide.

Spielberg received a bachelor's degree in biology from Princeton University and a doctorate in pharmacology from the University of Chicago. He graduated with honors from the University of Chicago Pritzker School of Medicine.

Issues of the new journal are available online at dij.sagepub.com/content/current. For more information about Spielberg and TIRS, visit www.diahome.org.

ABOUT DIA: DIA is a neutral, global, professional and member-driven association of nearly 18,000 professionals involved in the discovery, development and life cycle management of pharmaceuticals, biotechnology, medical devices and related health-care products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well-being worldwide. Headquarters are in Horsham, Pa., USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; Beijing, China; Washington, D.C. and Latin America. Visit our website at www.diahome.org; follow DIA on Facebook, Twitter (#druginfoassn), LinkedIn, Flickr and YouTube.

 

SOURCE DIA

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
One of the biggest challenges with adopting a DevOps mentality is: new applications are easily adapted to cloud-native, microservice-based, or containerized architectures - they can be built for them - but old applications need complex refactoring. On the other hand, these new technologies can require relearning or adapting new, oftentimes more complex, methodologies and tools to be ready for production. In his general session at @DevOpsSummit at 20th Cloud Expo, Chris Brown, Solutions Marketi...
SYS-CON Events announced today that CollabNet, a global leader in enterprise software development, release automation and DevOps solutions, will be a Bronze Sponsor of SYS-CON's 20th International Cloud Expo®, taking place from June 6-8, 2017, at the Javits Center in New York City, NY. CollabNet offers a broad range of solutions with the mission of helping modern organizations deliver quality software at speed. The company’s latest innovation, the DevOps Lifecycle Manager (DLM), supports Value S...
Cloud promises the agility required by today’s digital businesses. As organizations adopt cloud based infrastructures and services, their IT resources become increasingly dynamic and hybrid in nature. Managing these require modern IT operations and tools. In his session at 20th Cloud Expo, Raj Sundaram, Senior Principal Product Manager at CA Technologies, will discuss how to modernize your IT operations in order to proactively manage your hybrid cloud and IT environments. He will be sharing bes...
SYS-CON Events announced today that Outscale will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Outscale's technology makes an automated and adaptable Cloud available to businesses, supporting them in the most complex IT projects while controlling their operational aspects. You boost your IT infrastructure's reactivity, with request responses that only take a few seconds.
We all know that end users experience the internet primarily with mobile devices. From an app development perspective, we know that successfully responding to the needs of mobile customers depends on rapid DevOps – failing fast, in short, until the right solution evolves in your customers' relationship to your business. Whether you’re decomposing an SOA monolith, or developing a new application cloud natively, it’s not a question of using microservices - not doing so will be a path to eventual ...
SYS-CON Events announced today that Peak 10, Inc., a national IT infrastructure and cloud services provider, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Peak 10 provides reliable, tailored data center and network services, cloud and managed services. Its solutions are designed to scale and adapt to customers’ changing business needs, enabling them to lower costs, improve performance and focus intern...
Apache OpenWhisk on IBM Bluemix provides a powerful and flexible environment for deploying cloud-native applications driven by data, message, and API call events. In his session at 20th Cloud Expo, Daniel Krook, Software Architect, IBM Watson and Cloud Platform, and Distinguished IT Specialist, will discuss why serverless architectures are attractive for many emerging cloud workloads and when you should consider OpenWhisk for your next project. Then get started on Bluemix with three sample appl...
While presenting own advanced Robo-Advisory Platform, Michał Różański, Managing Partner at EARP and CEO at Empirica, will illustrate the most important issues of building tailored FinTech software in his session at 20th Cloud Expo. He will share experiences we have gained for over 6 years of developing solutions for financial institutions and FinTech companies, including robo-advisors. We welcome all FinTech innovators interested in how properly implemented technology can move their businesses f...
The 21st International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Digital Transformation, Machine Learning and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding busin...
Internet of @ThingsExpo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with the 21st International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. @ThingsExpo Silicon Valley Call for Papers is now open.
As cloud adoption continues to transform business, today's global enterprises are challenged with managing a growing amount of information living outside of the data center. The rapid adoption of IoT and increasingly mobile workforce are exacerbating the problem. Ensuring secure data sharing and efficient backup poses capacity and bandwidth considerations as well as policy and regulatory compliance issues.
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In his Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will explore t...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.
Automation is enabling enterprises to design, deploy, and manage more complex, hybrid cloud environments. Yet the people who manage these environments must be trained in and understanding these environments better than ever before. A new era of analytics and cognitive computing is adding intelligence, but also more complexity, to these cloud environments. How smart is your cloud? How smart should it be? In this power panel at 20th Cloud Expo, moderated by Conference Chair Roger Strukhoff, pane...
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.